Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2024  > 
Zeng Xinyue, Zhou Wangtianxu, Sun Qiquan. Research progress on kidney transplantation in China of 2023[J]. ORGAN TRANSPLANTATION. doi: 10.3969/j.issn.1674-7445.2024059
Citation: Zeng Xinyue, Zhou Wangtianxu, Sun Qiquan. Research progress on kidney transplantation in China of 2023[J]. ORGAN TRANSPLANTATION. doi: 10.3969/j.issn.1674-7445.2024059
shu

Research progress on kidney transplantation in China of 2023

doi: 10.3969/j.issn.1674-7445.2024059

  • Department of Kidney Transplantation, Guangdong Provincial People's Hospital Affiliated to Southern Medical University, Guangdong Academy of Medical Sciences, Guangzhou 510080, China

More Information
  • Corresponding author: Sun Qiquan, Email: sunqiq@mail.sysu.edu.cn
  • Received Date: 2024-01-30
    Available Online: 2024-03-07
    Abstract
  • Kidney transplantation has achieved significant success in treating end-stage renal disease. Nevertheless, it still faces a series of complex and significant challenges after surgery, such as infection, rejection, ischemia-reperfusion injury and chronic renal allograft dysfunction, etc. With the development of science and technology, including biomaterials, gene sequencing and other emerging technologies, Chinese researchers have launched a series of remarkable research in the field of kidney transplantation, aiming to solve these thorny issues. In 2023, relevant research of kidney transplantation in China not only focused on resolving the above challenges, but also highlighting on expanding novel technologies and concepts to build a brighter future of kidney transplantation. In this article, academic achievements of Chinese research teams in the field of kidney transplantation in 2023 were systematically reviewed, covering the frontiers of basic and clinical research and the application of emerging technologies, aiming to provide novel ideas and strategies for major clinical problems in the field of kidney transplantation from the local perspective and accelerate the advancement of kidney transplantation in China to a higher peak.

     

    • FullText(HTML)
  • loading
    • References(44)
  • [1]
    HARIHARAN S, ISRANI AK, DANOVITCH G. Long-term survival after kidney transplantation[J]. N Engl J Med, 2021, 385(8): 729-743. DOI: 10.1056/NEJMra2014530.
    [2]
    ZHAO H, ALAM A, SOO AP, et al. Ischemia-reperfusion injury reduces long term renal graft survival: mechanism and beyond[J]. EBioMedicine, 2018, 28: 31-42. DOI: 10.1016/j.ebiom.2018.01.025.
    [3]
    ZHU J, XIANG X, HU X, et al. miR-147 represses NDUFA4, inducing mitochondrial dysfunction and tubular damage in cold storage kidney transplantation[J]. J Am Soc Nephrol, 2023, 34(8): 1381-1397. DOI: 10.1681/ASN.0000000000000154.
    [4]
    SHI L, SONG Z, LI Y, et al. MiR-20a-5p alleviates kidney ischemia/reperfusion injury by targeting ACSL4-dependent ferroptosis[J]. Am J Transplant, 2023, 23(1): 11-25. DOI: 10.1016/j.ajt.2022.09.003.
    [5]
    LI X, PENG X, ZHOU X, et al. Small extracellular vesicles delivering lncRNA WAC-AS1 aggravate renal allograft ischemia-reperfusion injury by inducing ferroptosis propagation[J]. Cell Death Differ, 2023, 30(9): 2167-2186. DOI: 10.1038/s41418-023-01198-x.
    [6]
    YANG W, LI X, HE L, et al. Empagliflozin improves renal ischemia-reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK-OPA1 pathway promotion[J]. Cell Mol Biol Lett, 2023, 28(1): 42. DOI: 10.1186/s11658-023-00457-6.
    [7]
    SU L, ZHANG J, GOMEZ H, et al. Mitochondria ROS and mitophagy in acute kidney injury[J]. Autophagy, 2023, 19(2): 401-414. DOI: 10.1080/15548627.2022.2084862.
    [8]
    CHEN RY, LI DW, XIE H, et al. Gene signature and prediction model of the mitophagy-associated immune microenvironment in renal ischemia-reperfusion injury[J]. Front Immunol, 2023, 14: 1117297. DOI: 10.3389/fimmu.2023.1117297.
    [9]
    BERTAINA A, GRIMM PC, WEINBERG K, et al. Sequential stem cell-kidney transplantation in Schimke immuno-osseous dysplasia[J]. N Engl J Med, 2022, 386(24): 2295-2302. DOI: 10.1056/NEJMoa2117028.
    [10]
    SCHAUB S, HIRSCH HH, DICKENMANN M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy[J]. Am J Transplant, 2010, 10(12): 2615-2623. DOI: 10.1111/j.1600-6143.2010.03310.x.
    [11]
    LIU N, GU C, YANG Y, et al. Establishment and characterization of a novel reverse genetic system of BK polyomavirus[J]. J Med Virol, 2023, 95(8): e28995. DOI: 10.1002/jmv.28995.
    [12]
    YANG F, CHEN X, ZHANG H, et al. Single-cell transcriptome identifies the renal cell type tropism of human BK polyomavirus[J]. Int J Mol Sci, 2023, 24(2): 1330. DOI: 10.3390/ijms24021330.
    [13]
    LI D, REN Y, CHEN R, et al. Label-free MXene-assisted field effect transistor for the determination of IL-6 in patients with kidney transplantation infection[J]. Mikrochim Acta, 2023, 190(8): 284. DOI: 10.1007/s00604-023-05814-y.
    [14]
    MADHVAPATHY SR, WANG JJ, WANG H, et al. Implantable bioelectronic systems for early detection of kidney transplant rejection[J]. Science, 2023, 381(6662): 1105-1112. DOI: 10.1126/science.adh7726.
    [15]
    WANG Y, LIN X, WANG C, et al. Identification of PDCD1 as a potential biomarker in acute rejection after kidney transplantation via comprehensive bioinformatic analysis[J]. Front Immunol, 2023, 13: 1076546. DOI: 10.3389/fimmu.2022.1076546.
    [16]
    ZHANG Z, QIN Y, WANG Y, et al. Integrated analysis of cell-specific gene expression in peripheral blood using ISG15 as a marker of rejection in kidney transplantation[J]. Front Immunol, 2023, 14: 1153940. DOI: 10.3389/fimmu.2023.1153940.
    [17]
    LAI X, ZHENG X, MATHEW JM, et al. Tackling chronic kidney transplant rejection: challenges and promises[J]. Front Immunol, 2021, 12: 661643. DOI: 10.3389/fimmu.2021.661643.
    [18]
    LI J, WANG J, PAN T, et al. USP25 deficiency promotes T cell dysfunction and transplant acceptance via mitochondrial dynamics[J]. Int Immunopharmacol, 2023, 117: 109917. DOI: 10.1016/j.intimp.2023.109917.
    [19]
    ZHANG Y, HE J, YANG Z, et al. Preventative effect of TSPO ligands on mixed antibody-mediated rejection through a mitochondria-mediated metabolic disorder[J]. J Transl Med, 2023, 21(1): 295. DOI: 10.1186/s12967-023-04134-2.
    [20]
    GHONGE NP, MOHAN M, KASHYAP V, et al. Renal allograft dysfunction: evaluation with shear-wave sonoelastography[J]. Radiology, 2018, 288(1): 146-152. DOI: 10.1148/radiol.2018170577.
    [21]
    ZHANG J, ZHANG Y, FENG D, et al. Disruption of RCAN1.4 expression mediated by YY1/HDAC2 modulates chronic renal allograft interstitial fibrosis[J]. Cell Death Discov, 2023, 9(1): 271. DOI: 10.1038/s41420-023-01574-z.
    [22]
    ZHANG J, XIE W, NI B, et al. NSD2 modulates Drp1-mediated mitochondrial fission in chronic renal allograft interstitial fibrosis by methylating STAT1[J]. Pharmacol Res, 2024, 200: 107051. DOI: 10.1016/j.phrs.2023.107051.
    [23]
    ZHANG YH, LIU B, MENG Q, et al. Targeted changes in blood lipids improves fibrosis in renal allografts[J]. Lipids Health Dis, 2023, 22(1): 215. DOI: 10.1186/s12944-023-01978-x.
    [24]
    CHE YJ, REN XH, WANG ZW, et al. Lymph-node-targeted drug delivery for effective immunomodulation to prolong the long-term survival after heart transplantation[J]. Adv Mater, 2023, 35(16): e2207227. DOI: 10.1002/adma.202207227.
    [25]
    PAN Q, YOU Y, WANG X, et al. The impact of preformed and de novo HLA-DP antibodies in renal transplantation, a meta-analysis[J]. HLA, 2023, 101(2): 115-123. DOI: 10.1111/tan.14879.
    [26]
    GUO Z, ZHAO D, SA R, et al. A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy[J]. Front Immunol, 2023, 14: 1223567. DOI: 10.3389/fimmu.2023.1223567.
    [27]
    ZHU L, GUO Z, ZHAO D, et al. Case report: daratumumab for treatment of refractory late or chronic active antibody-mediated rejection in renal allograft recipients with high levels of de novo donor-specific antibodies[J]. Front Immunol, 2023, 13: 1087597. DOI: 10.3389/fimmu.2022.1087597.
    [28]
    ZHANG L, ZOU H, LU X, et al. Porcine anti-human lymphocyte immunoglobulin depletes the lymphocyte population to promote successful kidney transplantation[J]. Front Immunol, 2023, 14: 1124790. DOI: 10.3389/fimmu.2023.1124790.
    [29]
    LI Z, LU Z, HU C, et al. A machine learning analysis of prognostic genes associated with allograft tolerance after renal transplantation[J]. Cell Transplant, 2023, 32: 9636897231195116. DOI: 10.1177/09636897231195116.
    [30]
    ZHANG D, YE Y, HU X. A non-invasive piTreg-related gene signature for spontaneous tolerance in renal transplantation[J]. Gene, 2023, 848: 146901. DOI: 10.1016/j.gene.2022.146901.
    [31]
    WANG Y, YAN S, LIU Y, et al. Dynamic viral integration patterns actively participate in the progression of BK polyomavirus-associated diseases after renal transplantation[J]. Am J Transplant, 2023, 23(11): 1694-1708. DOI: 10.1016/j.ajt.2023.07.014.
    [32]
    ZHONG C, CHEN J, YAN Z, et al. Therapeutic strategies against BK polyomavirus infection in kidney transplant recipients: systematic review and meta-analysis[J]. Transpl Immunol, 2023, 81: 101953. DOI: 10.1016/j.trim.2023.101953.
    [33]
    WANG Q, LIAO G, XIA Q, et al. Safety and effectiveness of tigecycline combination therapy in renal transplant patients with infection due to carbapenem-resistant gram-negative bacteria[J]. Front Cell Infect Microbiol, 2023, 13: 1215288. DOI: 10.3389/fcimb.2023.1215288.
    [34]
    YANG D, WANG Y, ZHUANG B, et al. Nomogram based on high-frequency shear wave elastography (SWE) to evaluate chronic changes after kidney transplantation[J]. Eur Radiol, 2023, 33(2): 763-773. DOI: 10.1007/s00330-022-09054-1.
    [35]
    CAO Z, JIANG H, ZHAO C, et al. Up-regulation of PRKDC was associated with poor renal dysfunction after renal transplantation: a multi-centre analysis[J]. J Cell Mol Med, 2023, 27(10): 1362-1372. DOI: 10.1111/jcmm.17737.
    [36]
    YAN J, YANG X, WANG J, et al. Metabolic risk profile and graft function deterioration 2 years after kidney transplant[J]. JAMA Netw Open, 2023, 6(12): e2349538. DOI: 10.1001/jamanetworkopen.2023.49538.
    [37]
    BAI YJ, LI YM, HU SM, et al. Vitamin D supplementation reduced blood inflammatory cytokines expression and improved graft function in kidney transplant recipients[J]. Front Immunol, 2023, 14: 1152295. DOI: 10.3389/fimmu.2023.1152295.
    [38]
    LI Y, BAI Y, ZHANG H, et al. Decreased expression of ADAM10 on monocytes is associated with chronic allograft dysfunction in kidney transplant recipients[J]. Int Immunopharmacol, 2023, 115: 109710. DOI: 10.1016/j.intimp.2023.109710.
    [39]
    TIAN X, JI B, NIU X, et al. Efficacy and safety of low-dose aspirin on preventing transplant renal artery stenosis: a prospective randomized controlled trial[J]. Chin Med J (Engl), 2023, 136(5): 541-549. DOI: 10.1097/CM9.0000000000002574.
    [40]
    LI Y, TANG Y, LIN T, et al. Risk factors and outcomes of IgA nephropathy recurrence after kidney transplantation: a systematic review and meta-analysis[J]. Front Immunol, 2023, 14: 1277017. DOI: 10.3389/fimmu.2023.1277017.
    [41]
    TEJADA S, MARTINEZ-REVIEJO R, NOGUEIRA TA, et al. The effect of sex inequality on solid organ transplantation: a systematic review and meta-analysis[J]. Eur J Intern Med, 2023, 109: 58-67. DOI: 10.1016/j.ejim.2022.12.009.
    [42]
    ZHANG Q, SU X, LIU L, et al. The outcome of transplanting kidneys from very small pediatric deceased donors[J]. Transplantation, 2023, 107(7): 1564-1572. DOI: 10.1097/TP.0000000000004534.
    [43]
    YIN S, WU L, ZHANG F, et al. Expanding the donor pool: kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients[J]. Liver Int, 2023, 43(11): 2415-2424. DOI: 10.1111/liv.15703.
    [44]
    LIN X, LIU X, WU X, et al. Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation[J]. Expert Rev Anti Infect Ther, 2023, 21(2): 203-211. DOI: 10.1080/14787210.2023.2163237.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (67) PDF downloads(16) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return